XML 41 R26.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Investments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2017
Investments [Abstract] |
Schedule for fixed income securities at amortized cost, gross unrealized gains and losses and fair value | The amortized cost, gross unrealized gains and losses and fair value for fixed income securities are as follows:
($ in millions) | Amortized cost |  | Gross unrealized |  | Fair value
|  | Gains |  | Losses |
September 30, 2017 |  |  |  |  |  |  |  |  |  |  |
U.S. government and agencies | $ | 3,843 |  |  | $ | 65 |  |  | $ | (8 | ) |  | $ | 3,900 |
Municipal | 7,484 |  |  | 332 |  |  | (22 | ) |  | 7,794 |
Corporate | 43,259 |  |  | 1,419 |  |  | (132 | ) |  | 44,546 |
Foreign government | 1,077 |  |  | 30 |  |  | (14 | ) |  | 1,093 |
Asset-backed securities (“ABS”) | 1,263 |  |  | 16 |  |  | (9 | ) |  | 1,270 |
Residential mortgage-backed securities (“RMBS”) | 512 |  |  | 101 |  |  | (2 | ) |  | 611 |
Commercial mortgage-backed securities (“CMBS”) | 149 |  |  | 8 |  |  | (4 | ) |  | 153 |
Redeemable preferred stock | 21 |  |  | 3 |  |  | — |  |  | 24 |
Total fixed income securities | $ | 57,608 |  |  | $ | 1,974 |  |  | $ | (191 | ) |  | $ | 59,391 |
December 31, 2016 |  |  |  |  |  |  |  |  |  |  |
U.S. government and agencies | $ | 3,572 |  |  | $ | 74 |  |  | $ | (9 | ) |  | $ | 3,637 |
Municipal | 7,116 |  |  | 304 |  |  | (87 | ) |  | 7,333 |
Corporate | 42,742 |  |  | 1,178 |  |  | (319 | ) |  | 43,601 |
Foreign government | 1,043 |  |  | 36 |  |  | (4 | ) |  | 1,075 |
ABS | 1,169 |  |  | 13 |  |  | (11 | ) |  | 1,171 |
RMBS | 651 |  |  | 85 |  |  | (8 | ) |  | 728 |
CMBS | 262 |  |  | 17 |  |  | (9 | ) |  | 270 |
Redeemable preferred stock | 21 |  |  | 3 |  |  | — |  |  | 24 |
Total fixed income securities | $ | 56,576 |  |  | $ | 1,710 |  |  | $ | (447 | ) |  | $ | 57,839 |
Schedule for fixed income securities based on contractual maturities | The scheduled maturities for fixed income securities are as follows as of September 30, 2017:
($ in millions) | Amortized cost |  | Fair value
Due in one year or less | $ | 4,392 |  |  | $ | 4,415 |
Due after one year through five years | 29,466 |  |  | 30,044 |
Due after five years through ten years | 16,604 |  |  | 17,042 |
Due after ten years | 5,222 |  |  | 5,856 |
| 55,684 |  |  | 57,357 |
ABS, RMBS and CMBS | 1,924 |  |  | 2,034 |
Total | $ | 57,608 |  |  | $ | 59,391 |
Schedule of net investment income | Net investment income is as follows:
($ in millions) | Three months ended September 30, |  | Nine months ended September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Fixed income securities | $ | 519 |  |  | $ | 508 |  |  | $ | 1,564 |  |  | $ | 1,546 |
Equity securities | 37 |  |  | 31 |  |  | 130 |  |  | 103 |
Mortgage loans | 52 |  |  | 56 |  |  | 157 |  |  | 162 |
Limited partnership interests | 223 |  |  | 136 |  |  | 596 |  |  | 383 |
Short-term investments | 9 |  |  | 4 |  |  | 21 |  |  | 11 |
Other | 58 |  |  | 55 |  |  | 174 |  |  | 163 |
Investment income, before expense | 898 |  |  | 790 |  |  | 2,642 |  |  | 2,368 |
Investment expense | (55 | ) |  | (42 | ) |  | (154 | ) |  | (127 | )
Net investment income | $ | 843 |  |  | $ | 748 |  |  | $ | 2,488 |  |  | $ | 2,241 |
Schedule of realized capital gains and losses by asset type | Realized capital gains and losses by asset type are as follows:
($ in millions) | Three months ended September 30, |  | Nine months ended September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Fixed income securities | $ | 41 |  |  | $ | (1 | ) |  | $ | 78 |  |  | $ | (48 | )
Equity securities | 57 |  |  | 45 |  |  | 182 |  |  | (34 | )
Mortgage loans | 1 |  |  | — |  |  | 1 |  |  | 1 |
Limited partnership interests | 21 |  |  | 12 |  |  | 92 |  |  | 25 |
Derivatives | (17 | ) |  | (15 | ) |  | (40 | ) |  | (22 | )
Other | — |  |  | (8 | ) |  | 5 |  |  | (14 | )
Realized capital gains and losses | $ | 103 |  |  | $ | 33 |  |  | $ | 318 |  |  | $ | (92 | )
Schedule of realized capital gains and losses by transaction type | Realized capital gains and losses by transaction type are as follows:
($ in millions) | Three months ended September 30, |  | Nine months ended September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Impairment write-downs | $ | (23 | ) |  | $ | (63 | ) |  | $ | (94 | ) |  | $ | (185 | )
Change in intent write-downs | (5 | ) |  | (10 | ) |  | (43 | ) |  | (48 | )
Net other-than-temporary impairment losses recognized in earnings | (28 | ) |  | (73 | ) |  | (137 | ) |  | (233 | )
Sales and other | 148 |  |  | 121 |  |  | 495 |  |  | 166 |
Valuation and settlements of derivative instruments | (17 | ) |  | (15 | ) |  | (40 | ) |  | (25 | )
Realized capital gains and losses | $ | 103 |  |  | $ | 33 |  |  | $ | 318 |  |  | $ | (92 | )
Schedule of other-than-temporary impairment losses by asset type | Other-than-temporary impairment losses by asset type are as follows:
($ in millions) | Three months ended September 30, 2017 |  | Three months ended September 30, 2016
| Gross |  | Included in OCI |  | Net |  | Gross |  | Included in OCI |  | Net
Fixed income securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (13 | ) |  | $ | — |  |  | $ | (13 | )
ABS | — |  |  | (1 | ) |  | (1 | ) |  | — |  |  | — |  |  | — |
RMBS | — |  |  | — |  |  | — |  |  | (1 | ) |  | — |  |  | (1 | )
CMBS | (1 | ) |  | (1 | ) |  | (2 | ) |  | (3 | ) |  | — |  |  | (3 | )
Total fixed income securities | (1 | ) |  | (2 | ) |  | (3 | ) |  | (17 | ) |  | — |  |  | (17 | )
Equity securities | (8 | ) |  | — |  |  | (8 | ) |  | (27 | ) |  | — |  |  | (27 | )
Mortgage loans | (1 | ) |  | — |  |  | (1 | ) |  | — |  |  | — |  |  | — |
Limited partnership interests | (16 | ) |  | — |  |  | (16 | ) |  | (22 | ) |  | — |  |  | (22 | )
Other | — |  |  | — |  |  | — |  |  | (7 | ) |  | — |  |  | (7 | )
Other-than-temporary impairment losses | $ | (26 | ) |  | $ | (2 | ) |  | $ | (28 | ) |  | $ | (73 | ) |  | $ | — |  |  | $ | (73 | )
| Nine months ended September 30, 2017 |  | Nine months ended September 30, 2016
| Gross |  | Included in OCI |  | Net |  | Gross |  | Included in OCI |  | Net
Fixed income securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Municipal | $ | (1 | ) |  | $ | (2 | ) |  | $ | (3 | ) |  | $ | — |  |  | $ | — |  |  | $ | — |
Corporate | (9 | ) |  | 3 |  |  | (6 | ) |  | (30 | ) |  | 7 |  |  | (23 | )
ABS | (1 | ) |  | (1 | ) |  | (2 | ) |  | (6 | ) |  | — |  |  | (6 | )
RMBS | (1 | ) |  | (3 | ) |  | (4 | ) |  | (1 | ) |  | — |  |  | (1 | )
CMBS | (9 | ) |  | 1 |  |  | (8 | ) |  | (7 | ) |  | 1 |  |  | (6 | )
Total fixed income securities | (21 | ) |  | (2 | ) |  | (23 | ) |  | (44 | ) |  | 8 |  |  | (36 | )
Equity securities | (77 | ) |  | — |  |  | (77 | ) |  | (155 | ) |  | — |  |  | (155 | )
Mortgage loans | (1 | ) |  | — |  |  | (1 | ) |  | — |  |  | — |  |  | — |
Limited partnership interests | (32 | ) |  | — |  |  | (32 | ) |  | (33 | ) |  | — |  |  | (33 | )
Other | (4 | ) |  | — |  |  | (4 | ) |  | (9 | ) |  | — |  |  | (9 | )
Other-than-temporary impairment losses | $ | (135 | ) |  | $ | (2 | ) |  | $ | (137 | ) |  | $ | (241 | ) |  | $ | 8 |  |  | $ | (233 | )
Schedule of other-than-temporary impairment losses on fixed income securities included in Accumulated Other Comprehensive Income | The total amount of other-than-temporary impairment losses included in accumulated other comprehensive income at the time of impairment for fixed income securities, which were not included in earnings, are presented in the following table. The amounts exclude $213 million and $221 million as of September 30, 2017 and December 31, 2016, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date.
($ in millions) | September 30, 2017 |  | December 31, 2016
Municipal | $ | (5 | ) |  | $ | (8 | )
Corporate | (3 | ) |  | (7 | )
ABS | (15 | ) |  | (21 | )
RMBS | (80 | ) |  | (90 | )
CMBS | (5 | ) |  | (7 | )
Total | $ | (108 | ) |  | $ | (133 | )
Schedule of credit losses on fixed income securities recognized in earnings | Rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held as of the end of the period are as follows:
($ in millions) | Three months ended September 30, |  | Nine months ended September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Beginning balance | $ | (281 | ) |  | $ | (331 | ) |  | $ | (318 | ) |  | $ | (392 | )
Additional credit loss for securities previously other-than-temporarily impaired | (3 | ) |  | (3 | ) |  | (15 | ) |  | (14 | )
Additional credit loss for securities not previously other-than-temporarily impaired | — |  |  | (14 | ) |  | (8 | ) |  | (22 | )
Reduction in credit loss for securities disposed or collected | 20 |  |  | 12 |  |  | 76 |  |  | 92 |
Change in credit loss due to accretion of increase in cash flows | — |  |  | — |  |  | 1 |  |  | — |
Ending balance | $ | (264 | ) |  | $ | (336 | ) |  | $ | (264 | ) |  | $ | (336 | )
Schedule of unrealized net capital gains and losses | Unrealized net capital gains and losses included in accumulated other comprehensive income are as follows:
($ in millions) | Fair value |  | Gross unrealized |  | Unrealized net gains (losses)
September 30, 2017 |  | Gains |  | Losses |
Fixed income securities | $ | 59,391 |  |  | $ | 1,974 |  |  | $ | (191 | ) |  | $ | 1,783 |
Equity securities | 6,434 |  |  | 1,006 |  |  | (40 | ) |  | 966 |
Short-term investments | 2,198 |  |  | — |  |  | — |  |  | — |
Derivative instruments (1) | 1 |  |  | 2 |  |  | (4 | ) |  | (2 | )
Equity method (“EMA”) limited partnerships (2) |  |  |  |  |  |  |  |  |  | — |
Unrealized net capital gains and losses, pre-tax |  |  |  |  |  |  |  |  |  | 2,747 |
Amounts recognized for: |  |  |  |  |  |  |  |  |  |  |
Insurance reserves (3) |  |  |  |  |  |  |  |  |  | — |
DAC and DSI (4) |  |  |  |  |  |  |  |  |  | (203 | )
Amounts recognized |  |  |  |  |  |  |  |  |  | (203 | )
Deferred income taxes |  |  |  |  |  |  |  |  |  | (893 | )
Unrealized net capital gains and losses, after-tax |  |  |  |  |  |  |  |  |  | $ | 1,651 |
_______________
(1) | Included in the fair value of derivative instruments is $1 million classified as assets.
(2) | Unrealized net capital gains and losses for limited partnership interests represent the Company’s share of EMA limited partnerships’ other comprehensive income. Fair value and gross unrealized gains and losses are not applicable.
(3) | The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at current lower interest rates, resulting in a premium deficiency. Although the Company evaluates premium deficiencies on the combined performance of life insurance and immediate annuities with life contingencies, the adjustment, if any, primarily relates to structured settlement annuities with life contingencies, in addition to annuity buy-outs and certain payout annuities with life contingencies.
(4) | The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.
($ in millions) | Fair value |  | Gross unrealized |  | Unrealized net gains (losses)
December 31, 2016 |  | Gains |  | Losses |
Fixed income securities | $ | 57,839 |  |  | $ | 1,710 |  |  | $ | (447 | ) |  | $ | 1,263 |
Equity securities | 5,666 |  |  | 594 |  |  | (85 | ) |  | 509 |
Short-term investments | 4,288 |  |  | — |  |  | — |  |  | — |
Derivative instruments (1) | 5 |  |  | 5 |  |  | (3 | ) |  | 2 |
EMA limited partnerships |  |  |  |  |  |  |  |  |  | (4 | )
Unrealized net capital gains and losses, pre-tax |  |  |  |  |  |  |  |  |  | 1,770 |
Amounts recognized for: |  |  |  |  |  |  |  |  |  |  |
Insurance reserves |  |  |  |  |  |  |  |  |  | — |
DAC and DSI |  |  |  |  |  |  |  |  |  | (146 | )
Amounts recognized |  |  |  |  |  |  |  |  |  | (146 | )
Deferred income taxes |  |  |  |  |  |  |  |  |  | (571 | )
Unrealized net capital gains and losses, after-tax |  |  |  |  |  |  |  |  |  | $ | 1,053 |
_______________ (1) Included in the fair value of derivative instruments is $5 million classified as assets.
Schedule of change in unrealized net capital gains and losses | The change in unrealized net capital gains and losses for the nine months ended September 30, 2017 is as follows:
($ in millions) |
Fixed income securities | $ | 520 |
Equity securities | 457 |
Derivative instruments | (4 | )
EMA limited partnerships | 4 |
Total | 977 |
Amounts recognized for: |  |
Insurance reserves | — |
DAC and DSI | (57 | )
Amounts recognized | (57 | )
Deferred income taxes | (322 | )
Increase in unrealized net capital gains and losses, after-tax | $ | 598 |
Schedule of gross unrealized losses and fair value of available for sale securities by length of time | The following table summarizes the gross unrealized losses and fair value of fixed income and equity securities by the length of time that individual securities have been in a continuous unrealized loss position.
($ in millions) | Less than 12 months |  | 12 months or more |  | Total unrealized losses
| Number of issues |  | Fair value |  | Unrealized losses |  | Number of issues |  | Fair value |  | Unrealized losses |
September 30, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fixed income securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. government and agencies | 64 |  |  | $ | 2,625 |  |  | $ | (7 | ) |  | 7 |  |  | $ | 93 |  |  | $ | (1 | ) |  | $ | (8 | )
Municipal | 938 |  |  | 1,736 |  |  | (14 | ) |  | 83 |  |  | 172 |  |  | (8 | ) |  | (22 | )
Corporate | 560 |  |  | 7,468 |  |  | (74 | ) |  | 94 |  |  | 1,370 |  |  | (58 | ) |  | (132 | )
Foreign government | 68 |  |  | 697 |  |  | (14 | ) |  | — |  |  | — |  |  | — |  |  | (14 | )
ABS | 44 |  |  | 379 |  |  | (1 | ) |  | 10 |  |  | 34 |  |  | (8 | ) |  | (9 | )
RMBS | 84 |  |  | 42 |  |  | — |  |  | 176 |  |  | 57 |  |  | (2 | ) |  | (2 | )
CMBS | 5 |  |  | 20 |  |  | (2 | ) |  | 4 |  |  | 15 |  |  | (2 | ) |  | (4 | )
Total fixed income securities | 1,763 |  |  | 12,967 |  |  | (112 | ) |  | 374 |  |  | 1,741 |  |  | (79 | ) |  | (191 | )
Equity securities | 129 |  |  | 544 |  |  | (30 | ) |  | 17 |  |  | 48 |  |  | (10 | ) |  | (40 | )
Total fixed income and equity securities | 1,892 |  |  | $ | 13,511 |  |  | $ | (142 | ) |  | 391 |  |  | $ | 1,789 |  |  | $ | (89 | ) |  | $ | (231 | )
Investment grade fixed income securities | 1,689 |  |  | $ | 12,345 |  |  | $ | (96 | ) |  | 323 |  |  | $ | 1,530 |  |  | $ | (53 | ) |  | $ | (149 | )
Below investment grade fixed income securities | 74 |  |  | 622 |  |  | (16 | ) |  | 51 |  |  | 211 |  |  | (26 | ) |  | (42 | )
Total fixed income securities | 1,763 |  |  | $ | 12,967 |  |  | $ | (112 | ) |  | 374 |  |  | $ | 1,741 |  |  | $ | (79 | ) |  | $ | (191 | )
December 31, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fixed income securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. government and agencies | 46 |  |  | $ | 943 |  |  | $ | (9 | ) |  | — |  |  | $ | — |  |  | $ | — |  |  | $ | (9 | )
Municipal | 1,310 |  |  | 3,073 |  |  | (76 | ) |  | 8 |  |  | 29 |  |  | (11 | ) |  | (87 | )
Corporate | 862 |  |  | 13,343 |  |  | (256 | ) |  | 83 |  |  | 678 |  |  | (63 | ) |  | (319 | )
Foreign government | 41 |  |  | 225 |  |  | (4 | ) |  | — |  |  | — |  |  | — |  |  | (4 | )
ABS | 31 |  |  | 222 |  |  | (1 | ) |  | 14 |  |  | 109 |  |  | (10 | ) |  | (11 | )
RMBS | 89 |  |  | 53 |  |  | (1 | ) |  | 179 |  |  | 91 |  |  | (7 | ) |  | (8 | )
CMBS | 15 |  |  | 59 |  |  | (4 | ) |  | 4 |  |  | 15 |  |  | (5 | ) |  | (9 | )
Redeemable preferred stock | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Total fixed income securities | 2,395 |  |  | 17,918 |  |  | (351 | ) |  | 288 |  |  | 922 |  |  | (96 | ) |  | (447 | )
Equity securities | 195 |  |  | 654 |  |  | (56 | ) |  | 46 |  |  | 165 |  |  | (29 | ) |  | (85 | )
Total fixed income and equity securities | 2,590 |  |  | $ | 18,572 |  |  | $ | (407 | ) |  | 334 |  |  | $ | 1,087 |  |  | $ | (125 | ) |  | $ | (532 | )
Investment grade fixed income securities | 2,202 |  |  | $ | 15,678 |  |  | $ | (293 | ) |  | 201 |  |  | $ | 493 |  |  | $ | (51 | ) |  | $ | (344 | )
Below investment grade fixed income securities | 193 |  |  | 2,240 |  |  | (58 | ) |  | 87 |  |  | 429 |  |  | (45 | ) |  | (103 | )
Total fixed income securities | 2,395 |  |  | $ | 17,918 |  |  | $ | (351 | ) |  | 288 |  |  | $ | 922 |  |  | $ | (96 | ) |  | $ | (447 | )
Carrying value of non-impaired fixed and variable rate mortgage loans by debt service coverage ratio distribution | The following table reflects the carrying value of non-impaired fixed rate and variable rate mortgage loans summarized by debt service coverage ratio distribution.
($ in millions) | September 30, 2017 |  | December 31, 2016
Debt service coverage ratio distribution | Fixed rate mortgage loans |  | Variable rate mortgage loans |  | Total |  | Fixed rate mortgage loans |  | Variable rate mortgage loans |  | Total
Below 1.0 | $ | 4 |  |  | $ | — |  |  | $ | 4 |  |  | $ | 60 |  |  | $ | — |  |  | $ | 60 |
1.0 - 1.25 | 349 |  |  | — |  |  | 349 |  |  | 324 |  |  | — |  |  | 324 |
1.26 - 1.50 | 1,111 |  |  | — |  |  | 1,111 |  |  | 1,293 |  |  | — |  |  | 1,293 |
Above 1.50 | 2,804 |  |  | 39 |  |  | 2,843 |  |  | 2,765 |  |  | 39 |  |  | 2,804 |
Total non-impaired mortgage loans | $ | 4,268 |  |  | $ | 39 |  |  | $ | 4,307 |  |  | $ | 4,442 |  |  | $ | 39 |  |  | $ | 4,481 |
Net carrying value of impaired mortgage loans | The net carrying value of impaired mortgage loans is as follows:
($ in millions) | September 30, 2017 |  | December 31, 2016
Impaired mortgage loans with a valuation allowance | $ | 15 |  |  | $ | 5 |
Impaired mortgage loans without a valuation allowance | — |  |  | — |
Total impaired mortgage loans | $ | 15 |  |  | $ | 5 |
Valuation allowance on impaired mortgage loans | $ | 4 |  |  | $ | 3 |
Valuation allowance on impaired mortgage loans | The rollforward of the valuation allowance on impaired mortgage loans is as follows:
($ in millions) | Three months ended September 30, |  | Nine months ended September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Beginning balance | $ | 3 |  |  | $ | 3 |  |  | $ | 3 |  |  | $ | 3 |
Net increase in valuation allowance | 1 |  |  | — |  |  | 1 |  |  | — |
Charge offs | — |  |  | — |  |  | — |  |  | — |
Ending balance | $ | 4 |  |  | $ | 3 |  |  | $ | 4 |  |  | $ | 3 |

X
- Definition This item represents the schedule of change in unrealized net capital gains and losses by type of securities. + References No definition available. + Details
Name: | all_ScheduleOfChangeInUnrealizedNetCapitalGainsAndLossesTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition This item represents the schedule of realized gains and losses reported in the statement of income by type of securities. + References No definition available. + Details
Name: | all_ScheduleOfGainLossOnInvestmentsBySecurityTypeTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition This item represents the schedule of realized gains and losses reported in the statement of income by type of transactions. + References No definition available. + Details
Name: | all_ScheduleOfGainLossOnInvestmentsByTransactionTypeTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents the schedule of net carrying value and the related valuation allowance of impaired mortgage loans. + References No definition available. + Details
Name: | all_ScheduleOfNetCarryingValueOfImpairedMortgageLoansTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition This item represents the schedule of other-than-temporary impairment losses recognized in statement of income and other comprehensive income by asset type. + References No definition available. + Details
Name: | all_ScheduleOfOtherThanTemporaryImpairmentLossesByAssetTypeTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition This item represents the schedule of other-than-temporary impairment losses on fixed income securities included in Accumulated Other Comprehensive Income. + References No definition available. + Details
Name: | all_ScheduleOfOtherThanTemporaryImpairmentLossesOnFixedIncomeSecuritiesIncludedInAccumulatedOtherComprehensiveIncomeTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition This item represents the schedule of unrealized net capital gains and losses recorded in accumulated other comprehensive income by type of securities. + References No definition available. + Details
Name: | all_ScheduleOfUnrealizedCapitalGainsAndLossesIncludedInAccumulatedOtherComprehensiveIncomeTableTextBlock
Namespace Prefix: | all_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition A table of investments, shown as a text block. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 6 -Section 10 -Paragraph (c) -Subparagraph (1) + Details
Name: | invest_InvestmentTableTextBlock
Namespace Prefix: | invest_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financing receivables (examples of financing receivables include loans, trade accounts receivable and notes receivable) and activity in the allowance for credit losses account. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 11B -URI http://asc.fasb.org/extlink&oid=84173941&loc=SL6953423-111524 + Details
Name: | us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 55 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=82894031&loc=SL6953803-111525 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=84173941&loc=SL6953659-111524 + Details
Name: | us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.2) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.8) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(a),(b)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_InvestmentIncomeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. + References No definition available. + Details
Name: | us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of other than temporary impairment (OTTI) related to credit losses recognized in earnings including: (a) the beginning balance of the amount related to credit losses on debt securities held by the investor at the beginning of the period for which a portion of an OTTI was recognized in other comprehensive income; (b) additions for the amount related to the credit loss for which an OTTI was not previously recognized; (c) reductions for securities sold during the period (realized); (d) reductions for securities for which the amount previously recognized in other comprehensive income was recognized in earnings because the investor intends to sell the security or more likely than not will be required to sell the security before recovery of its amortized cost basis; (e) additional increases to the amount related to the credit loss for which an OTTI was previously recognized when the investor does not intend to sell the security and it is not more likely than not that the investor will be required to sell the security before recovery of its amortized cost basis; (f) reductions for increases in cash flows expected to be collected that are recognized over the remaining life of the security; and (g) the ending balance of the amount related to credit losses on debt securities held by the entity at the end of the period for which a portion of an OTTI was recognized in other comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27340-111563 + Details
Name: | us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27290-111563 + Details
Name: | us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration